DNM2 and skin basal cell carcinoma: The efficiency of these constructs in BCC was evaluated using an anti-dopamine-beta-hydroxylase (DBH) antibody internalization assay to monitor compensatory endocytosis of chromaffin granules [32], a process known to be dependent on dynamin-2 [28].